Ag Sec. Rollins takes new actions to reduce burdens on the U.S. pork and poultry industries

Ag Secretary Brooke Rollins announced she is taking action to streamline pork and poultry processing, starting with line speeds.

Rollins says the Food Safety and Inspection Service will extend waivers, allowing pork and poultry facilities to keep line speeds higher. It is an area that USDA has studied extensively over the years and across Administrations.

She notes these studies have proven no link between processing speeds and injuries. Rollins says these moves are important to meet demand without excessive government interference. Rulemaking will start right away.

Related Stories
Ag Secretary Brooke Rollins told RFD-TV’s Kirbe Schnoor that the Farm Bill is an important piece of legislation and one that she feels “really good about.”
Ag Secretary Brooke Rollins told RFD-TV’s Kirbe Schnoor that trade is unpredictable, and that President Trump is committed to making America’s producers part of that conversation.

LATEST STORIES BY THIS AUTHOR:

These “USDA Foods” are provided to USDA’s Food and Nutrition Service (FNS) nutrition assistance programs, including food banks that operate The Emergency Food Assistance Program (TEFAP), and are a vital component of the nation’s food safety net.
Tyson’s closure reflects deep supply shortages in the U.S. cattle industry, tightening packing capacity, weakening competition, and signaling more volatility ahead for cow-calf producers and feedyards.
Gary Hall, co-founder of Hollywood Impact Studios Rehabilitation, joined the program to discuss using agriculture to provide opportunities and mentorship for at-risk youth in Southern California.
The agriculture workforce remains strong and diverse, offering meaningful pathways for students pursuing careers that support the food and farm economy.
Screwworm.gov has targeted resources for a wide range of stakeholders, including livestock producers, veterinarians, animal health officials, wildlife professionals, healthcare providers, pet owners, researchers, drug manufacturers, and the general public.